Related Experiment Video

Updated: Jul 3, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

The utility of cells as vehicles for oncolytic virus therapies

Stephen J Russell1, Kah Whye Peng

  • 1Mayo Clinic, Department of Molecular Medicine, 200 1st Street SW, Rochester, MN 55905, USA. sjr@mayo.edu

Current Opinion in Molecular Therapeutics
|August 7, 2008
PubMed

Insights

Efficiently delivering oncolytic viruses for cancer treatment is challenging. Using virus-infected carrier cells offers a promising strategy to overcome immune barriers and improve tumor targeting, even in immune patients.

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Oncolytic viruses show potential as cancer therapeutics.
  • Challenges include immune neutralization and poor tumor penetration.
  • Current delivery methods face significant obstacles for effective cancer treatment.

Purpose of the Study:

  • To investigate virus-infected carrier cells as a novel delivery system for oncolytic viruses.
  • To overcome challenges associated with direct virus administration.
  • To explore enhanced tumor targeting and efficacy in cancer therapy.

Main Methods:

  • Utilizing virus-infected carrier cells for enhanced delivery of oncolytic viruses.
  • Investigating the ability of carrier cells to bypass immune surveillance.
  • Evaluating the synergistic antitumor effects of carrier cells and oncolytic viruses.

Main Results:

  • Virus-infected carrier cells demonstrate improved delivery and dispersal of oncolytic viruses to tumors.
  • Carrier cells can overcome pre-existing antiviral immunity.
  • Potential for synergistic antitumor activity leading to tumor regression.

Conclusions:

  • Virus-infected carrier cells represent a viable strategy for improving oncolytic virotherapy.
  • This approach enhances the efficiency and safety of oncolytic virus delivery.
  • Carrier cell-mediated delivery holds promise for more effective cancer treatment.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...